📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.
In 2025, Zydus Lifesciences completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Zydus Lifesciences has also provided a category-level breakdown for 6 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Zydus Lifesciences’s data sources below and access millions more through our Disclosure Search.
In 2025, the total operational greenhouse gas (GHG) emissions ofZydus Lifesciences amounted to261,630.95metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Zydus Lifesciencesincreased by 1.62%, suggesting that the company faced challenges in reducing its emissions from its core operations.a
In 2025, the total Scope 1 emissions of Zydus Lifesciences were 56,459.38 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Since 2022, Zydus Lifesciences's Scope 1 emissions have decreased by 5.23%, reflecting a declining long-term trend in Scope 1 emissions over time.ab
Compared to the previous year(2024), Zydus Lifesciences's Scope 1 emissions decreased by 13.75%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a
In 2025, Zydus Lifesciences reported Scope 2 greenhouse gas (GHG) emissions of 205,171.57 tCOâ‚‚e without specifying the calculation method.a
Compared to the previous year(2024), Zydus Lifesciences's Scope 2 emissions(Unspecified Calculation Method) have remained relatively stable, indicating that Zydus Lifesciences's emissions have plateaued with no significant change in its energy consumption footprint.a
In 2025, Zydus Lifesciences reported its Scope 2 emissions using an unspecified methodology.a
In 2025, Zydus Lifesciences reported 66,915.74 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2025 disclosure of Zydus Lifesciences includes a breakdown across 6of the 15 Scope 3 categories defined by the GHG Protocol,matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
In 2025, Zydus Lifesciences reported total Scope 3 emissions of 66,915.74 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Approximately 100%of these emissions originated from upstream activities such as purchased goods and capital goods, while 0%came from downstream activities like product use, distribution, and end-of-life treatment.a
Since 2022, Zydus Lifesciences's Scope 3 emissionshave increased by 637.61%, reflecting a rising long-term trend in Scope 3 emissions over time.ab
Compared to the previous year (2024), Zydus Lifesciences's Scope 3 emissions increased by 30.28%, suggesting that the company faced challenges in reducing emissions across its value chain.a
In 2025, Zydus Lifesciences reported emissions for 6 out of the 15 Scope 3 categories defined by the GHG Protocol.a
This partial disclosure allows for some insight into the company's indirect impacts.
In 2025, the largest contributors to Zydus Lifesciences's Scope 3 emissions were:a
In 2025, Zydus Lifesciences reported Scope 1 greenhouse gas (GHG) emissions of 56,459.38 tCOâ‚‚e and total revenues of USD 2,642 millions. This translates into an emissions intensity of 21.37 tCOâ‚‚e per millions USD.a
In 2025, Zydus Lifesciences reported a Scope 1 emissions intensity of 21.37 tCOâ‚‚e per millions USD. Compared to the peer group median of 24.05, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
In 2025, Zydus Lifesciences ranked 11 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a
Zydus Lifesciences is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a
In 2025, Zydus Lifesciences reported a total carbon footprint of 328,546.69 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 6.38% increase compared to 2024, suggesting a rise in emissions across its operations or value chain.a
The largest contributor to Zydus Lifesciences's total carbon footprint was Scope 2 emissions, accounting for 62.45% of the company's total carbon footprint, followed by Scope 3 emissions at 20.37%.a